Celanese에 대한 매도 수량은 투자자에게 Celanese의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Celanese (NYSE:CE) 주식, 공매도 수량 보고

Celanese

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

CHWY

SRCL

WYNN

월요일 아침 (현지 시간 기준) 미국 주식 선물 거래가 혼조세를 보이고 있는 가운데, 오늘 투자자들의 관심을 끌 수 있는 일부 주식은 다음과 같다:1. 월스트리트는 콘스텔레이션 에너지(NASDAQ:CEG)이 개장 전에 57억 1천만 달러의 매출과 57억 1천만 달러의 주당 2.64달러의 분기 이익을 보고할 것으로 예상하고 있다. 콘스텔레이션 에너지의 주가는 시간외 거래에서 5.5% 하락한 243.99달러를 기록했다.

월요일 주목해야 할 주식: 메리어트, 콘스텔레이션 에너지, 츄이, 윈 리조트 및 셀라니즈

Asia

Government

Regulations

Eurozone

Politics

Global

Markets

AHKSY

BASFY

MTLHY

SABRY

중국은 미국과 유럽 연합에서 만든 플라스틱에 대한 새로운 반덤핑 조사를 시작하면서 서구와의 현재 진행 중인 경제 전쟁에서 새로운 단계를 밟았다. 이번 조치는 최근 조 바이든 대통령이 주도한 중국산 수입품에 대한 관세 인상 등 서방 국가들의 최근 보호주의 조치에 대한 보복 조치로 읽힐 수 있다.

중국, 바이든의 관세에 대응하여 새로운 플라스틱 수입 조사로 반격: 6개 주식이 피해 우려

Celanese Corp

CEA Industries Inc

Creations Inc

CENTRAL AUTOMOTIVE PRODS by Central Automotive Products Ltd.

Central Automotive Products Ltd

China Eastern Airlines Corp Ltd ADR

CHINA EVERBRIGHT BANK ORD by China Everbright Bank Co Ltd.

China Everbright Bank Co Ltd

CITYCHAMP WATCH & JEWELLE by Citychamp Watch & Jewellery Group Ltd.

Citychamp Watch & Jewellery Group Ltd

Cebu Air Inc

CANASIA ENERGY CORP by CANASIA ENERGY CORP.

CanAsia Energy Corp

Saltbae Capital Corp

Cecil Bancorp Inc

CECO Environmental Corp

The Central and Eastern Europe Fund, Inc. (The) Common Stock

CENTRAL & EASTERN EUROPE FUND, INC.

Ceres Inc

CEEK VR

UpSnap Inc

Sprott Physical Gold and Silver Trust Units

Sprott Physical Gold and Silver Trust

Global X S&P Catholic Values Developed ex-U.S. ETF

CENTRAL FLA ST BK BELLEVW by Central Florida State Bank (Belleview FL)

COMML NATL FINCL CRP MICH by Commercial National Financial Corp (MI)

Commercial National Financial Corp (MI)

ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN

Saba Closed-End Funds ETF

Constellation Energy Corporation - Common Stock

Constellation Energy Corp

CHINA ED GROUP HLDGS LTD by CHINA ED GROUP HLDGS LTD.

China Education Group Holdings Ltd

CERRO GRANDE MINING CORP by Cerro Grande Mining Corp.

Cerro Grande Mining Corp

COSMO ENERGY HLDGS CO LTD by Cosmo Energy Hldgs Co Ltd

Cosmo Energy Holdings Co Ltd

Camber Energy Inc OM PAR $0.001 2022 NEW

COELACANTH ENERGY INC by COELACANTH ENERGY INC

Coelacanth Energy Inc

Camber Energy Inc

CONSOL Energy Inc

Cresco Ltd

Celsius - United States dollar

Celcuity Inc

Bristol-Myers Squibb Company Celegne Contingent Value Rights

Celsius Holdings Inc

CELLCOM ISRAEL LTD ORD by Cellcom Israel, Ltd.

Cellcom Israel Ltd

Cellframe

Celo - United States dollar

Celer Network - United States dollar

Centamin PLC

Celularity Inc

PREFERRED COMMERCE INC by Preferred Commerce Inc.

Preferred Commerce Inc

Celexpress Inc

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Technology Holdings Inc

ClearBridge MLP & Midstream Fund Inc Com (New)

iShares J.P. Morgan EM Corporate Bond ETF

CEN Biotech Inc

Caravan Energy Corp Ordinary Shares

CareNet Inc

Cenntro Inc

CENNZnet

Central Garden & Pet Company - Common Stock

Central Garden & Pet Co

Central Garden & Pet Company - Class A Common Stock Nonvoting

Century Aluminum Co

CEO America Inc

CeCors Inc

Cantor Equity Partners, Inc. - Class A ordinary shares

Cantor Equity Partners Inc

REX Crypto Equity Premium Income ETF

CEPS PLC

Central Puerto S.A. American Depositary Shares (each represents ten Common Shares)

Central Puerto SA

Crestwood Equity Partners LP Unit Ltd Partnership Int (New)

CERES INC OM NEW

Cere Network

CERES GLOBAL AG CORP ORD by Ceres Global Ag Corp.

Ceres Global Ag Corp

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

Cerus Corp

Certara Inc

COLOMBIA ENERGY RESOUR by Colombia Energy Resources, Inc.

Colombia Energy Resources Inc

SPDR Series Trust SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF

CES ENERGY SOLUTIONS ORD by CES Energy Solutions Corp.

CES Energy Solutions Corp

Chesser Resources Ltd

CHINESE ESTS HLDGS ORD by Chinese Estates Holdings Ltd.

Chinese Estates Holdings Ltd

CHINESE ESTS HLD UNSP/ADR by Chinese Estates Holdings Ltd.

CES Synergies Inc

Central Securities Corporation Common Stock

Central Securities Corp

CoinEx Token

ACT Energy Technologies Ltd

ACT ENERGY TECHS LTD by ACT Energy Technologies Ltd.

DriveWealth ETF Trust DriveWealth NYSE 100 Index ETF

CAPITAL CITY ENERGY GROUP by Capital City Energy Group, Inc.

21Shares Core Ethereum ETF

CYBER ENVIRO-TECH INC. by Cyber Enviro-Tech Inc.

Cyber Enviro-Tech Inc

CHINA ECOTOURISM GRP NEW by CHINA ECOTOURISM GROUP LTD.

CETUS CAP ACQUISITION CORP L A

CETUS CAP ACQUISITION CORP RT

CETUS CAP ACQUISITION CORP UNIT 1 CL A & 1 WT EXP & 1 RT

CETUS CAP ACQUISITION CORP WT EXP

Cemtrex Inc

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) has been analyzed by 15 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $106.07, a high estimate of $163.00, and a low estimate of $73.00. Highlighting a 24.81% decrease, the current average has fallen from the previous average price target of $141.07. 
<img src="https://www.benzinga.com/files/images/story/2024/1734634861_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Celanese is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$88.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$73.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Celanese. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Celanese's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Celanese's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>All You Need to Know About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>A Deep Dive into Celanese's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Celanese faced challenges, resulting in a decline of approximately -2.75% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Celanese's net margin is impressive, surpassing industry averages. With a net margin of 4.38%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Celanese's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Celanese's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.45%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Forecasting The Future: 15 Analyst Projections For Celanese

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $122 to $88.

News

Price Target

RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $88

Citigroup analyst Patrick Cunningham maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Neutral and lowers the price target from $100 to $73.

Citigroup Maintains Neutral on Celanese, Lowers Price Target to $73

Celanese's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) short percent of float has fallen 8.89% since its last report. The company recently reported that it has 5.07 million shares sold short, which is 7.28% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Celanese Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733855414_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celanese has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Celanese's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Celanese's peer group average for short interest as a percentage of float is 2.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Celanese's Recent Short Interest

Management

Celanese Names Edward Galante, An Independent Director On Board Since 2013, As Chair Of Board

Celanese Names Scott Richardson, Currently Its COO, As CEO; Lori Ryerkerk Is Stepping Down As Chairman, CEO  And Director At End Of The Year

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul>
<li>On Nov. 11, UBS downgraded the stock from Buy to Neutral and lowered its price target from $161 to $97. The company's stock fell around 10% over the past month and has a <a href="https://www.benzinga.com/quote/CE">52-week low of $68.88</a>.</li>
<li>RSI Value: 25.90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>CE Price Action: Shares of Celanese gained 1.6% to close at $70.54 on Friday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> latest CE news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png" alt="" class="wp-image-682682" style="width:611px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035629/image-55-768x702.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure>
<h3 class="wp-block-heading">Dow Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Dec. 3, Dow announced the appointment of Karen S. Carter as Chief Operating Officer. &#8220;Karen is a proven leader with more than three decades of experience at Dow delivering strong business results,&#8221; said Dow Chair and Chief Executive Officer Jim Fitterling. &#8220;She has an excellent track record of operating discipline, maintaining close relationships with key partners and customers, and driving innovation across the organization. She has successfully led our largest business and played critical leadership roles in other essential business and functional teams within Dow, always with a focus on developing and maintaining high-performing teams.&#8221; The company's stock fell around 9% over the past month and <a href="https://www.benzinga.com/quote/DOW">has a 52-week low </a>of $41.73.</li>
<li>RSI Value: 24.25</li>
<li>DOW Price Action: Shares of Dow fell 0.5% to close at $41.99 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"> trend in DOW stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="917" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png" alt="" class="wp-image-682687" style="width:552px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57.png 917w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035736/image-57-768x709.png 768w" sizes="(max-width: 917px) 100vw, 917px" /></a></figure>
<h3 class="wp-block-heading">Braskem SA ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>)</h3>
<ul>
<li>On Sept. 18, UBS upgraded the stock from Neutral to Buy and raised its price target from $7.7 to $10. The company's stock fell around 12% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/BAK">low of $4.68</a>.</li>
<li>RSI Value: 24.38</li>
<li>BAK Price Action: Shares of Braskem fell 5.8% to close at $4.82 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1">breakout in BAK shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent120924&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="895" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png" alt="" class="wp-image-682689" style="width:583px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/09035826/image-58-768x719.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42380712/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Top 3 Materials Stocks That May Rocket Higher In December

Across the recent three months, 14 analysts have shared their insights on Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $112.86, a high estimate of $163.00, and a low estimate of $76.00. This current average represents a 24.1% decrease from the previous average price target of $148.69. 
<img src="https://www.benzinga.com/files/images/story/2024/1732042869_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Celanese among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$88.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$97.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>John McNulty</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$76.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$98.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Ghansham Panjabi</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$100.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Kieran De Brun</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Kevin McCarthy</td>
<td>Vertical Research</td>
<td>Announces</td>
<td>Sell</td>
<td>$130.00</td>
<td>-</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$163.00</td>
<td>$167.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$180.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Celanese. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Celanese compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Celanese's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Celanese's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Celanese analyst ratings.</a>
<h2>About Celanese</h2>
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
<h3>Celanese: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Celanese's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -2.75%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Celanese's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 4.38%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 1.61%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Celanese's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.45%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a high debt-to-equity ratio of 1.83, Celanese faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Celanese

Barclays analyst Michael Leithead maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $101 to $88.

Barclays Maintains Equal-Weight on Celanese, Lowers Price Target to $88

President-elect Donald Trump ran on a promise to <a href="https://www.benzinga.com/news/24/09/40703958/trumps-drill-baby-drill-pledge-may-not-deliver-promised-energy-price-cuts-experts-warn">&#8220;drill, baby, drill&#8221;</a> in his second term in office, reflecting his continued support of the fossil fuel industry. His stance on nuclear energy, however, is murky.
What Happened: Following his 2016 election win, Trump <a href="https://www.benzinga.com/news/16/12/8836138/trump-says-we-must-greatly-strengthen-expand-nuclear-capability">called for efforts to strengthen</a> U.S. nuclear energy. During his first term, his administration advanced several nuclear microreactor projects, <a href="https://www.energy.gov/ne/photos/11-accomplishments-trump-administration-advanced-nuclear-energy">according</a> to the Department of Energy.
However, he may have flip-flopped on the issue. In an interview with podcaster Joe Rogan ahead of the Nov. 5 election, Trump seemingly highlighted the dangers of pushing nuclear energy, <a href="https://www.huffpost.com/entry/trump-joe-rogan-nuclear-energy_n_671ec211e4b0448bcdb1e742">according</a> to the Huffington Post.
"They get too big and too complex and too expensive," Trump said. "There's a little danger to nuclear—you know, we had some really bad nuclear."
He then named several nuclear projects that have stalled in recent years.
Robert F. Kennedy Jr., an ally of Trump and a <a href="https://kalshi.com/markets/kxfda/next-fda-administrator">possible</a> Trump appointee, has an anti-nuclear track record, <a href="https://www.utilitydive.com/news/nuclear-energy-sector-mixed-views-second-trump-administration-joe-rogan/732407/">according</a> to Utility Dive.
See Also: <a href="https://www.benzinga.com/personal-finance/24/10/41313947/expert-finds-trumps-tax-proposal-drains-money-from-95-of-households-and-funnels-it-to-the-top-5-">Expert Finds Trump&#8217;s Tax Proposal Drains Money From 95% Of Households And Funnels It To The Top 5%</a>
Why it Matters: A future widespread adoption of nuclear energy <a href="https://www.benzinga.com/news/24/09/41020113/sam-altmans-openai-pushes-biden-administration-for-massive-5gw-data-centers-equivalent-to-output-of">necessitates significant investments</a> in data centers. In turn, data centers require substantially higher amounts of electricity. 
Artificial intelligence is <a href="https://www.benzinga.com/markets/esg/24/08/40589781/power-hungry-ai-revives-interest-in-nuclear-energy-michigan-to-reopen-closed-plant-for-first-time-in">projected to use</a> between 8% and 25% of all U.S. electricity by 2030.
Facts show that President Joe Biden&#8216;s administration produced <a href="https://www.benzinga.com/government/23/10/35240230/us-is-producing-more-oil-under-biden-than-at-any-point-under-the-trump-administration">more oil than Trump&#8217;s previous administration</a>. He also prioritized nuclear as a clean energy source. The one-term president positioned it as a bridge energy source that provides reliable, carbon-free electricity.
The Market Reacts: Regardless of whether he centers nuclear energy as a key part of his domestic agenda, Trump&#8217;s support of deregulation would likely serve as a tailwind.
Shares of Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) have traded up over 13% since Trump&#8217;s election win. Constellation Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CE#NASDAQ">CE</a>) has fared worse, trading down nearly 3%.
Small reactor companies have seen even more pronounced gains. Shares of Nuscale Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) are up over 20%. Meanwhile, Nano Nuclear Energy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) has shot up over 26%.
The Trump-Nuclear trade has seemingly died down on Monday and Tuesday. 
Also Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/24/11/41909846/trumps-treasury-pick-frontrunner-scott-bessent-could-shift-wall-street-crypto">Trump&#8217;s Treasury Pick Frontrunner Scott Bessent Could Shift Wall Street, Crypto</a></li>
</ul>

Trump's Fossil Fuel Push May Satisfy AI's Soaring Energy Demand — But What About Nuclear?

WIIM

Celanese shares are trading lower after UBS downgraded the stock from Buy to Neutral and lowered its price target from $161 to $97.

UBS analyst Joshua Spector downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Buy to Neutral and lowers the price target from $161 to $97.

Downgrades

UBS Downgrades Celanese to Neutral, Lowers Price Target to $97

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587f78d077f9dd000126ef0f/john-difucci">Guggenheim analyst John Difucci</a> downgraded the rating for Smartsheet Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) from Buy to Neutral. Smartsheet shares closed at $56.02 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Constantine Davides downgraded the rating for agilon health, inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) from Market Outperform to Market Perform. Agilon Health shares closed at $1.84 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5abbc11ab0230000019a9b76/john-mcnulty">BMO Capital analyst John McNulty</a> downgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Market Perform to Underperform and lowered the price target from $138 to $76. Celanese shares closed at $84.80 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Seaport Global analyst Kenneth Zener downgraded the rating for NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>) from Buy to Neutral. NVR shares closed at $9,306.94 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst James Rollyson downgraded Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) from Strong Buy to Outperform and slashed the price target from $131 to $102. Tidewater shares closed at $56.07 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="546" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-1024x546.png" alt="" class="wp-image-640254" style="width:508px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-1024x546.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/11071418/image-108.png 1242w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41871463/dow-sp-500-notch-best-week-of-year-as-tesla-surges-post-trump-win-investor-sentiment-improves-fear-greed-index-remains-in-neutral-zone">Dow, S&amp;P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear &amp; Greed Index Remains In &#8216;Neutral&#8217; Zone</a></li>
</ul>

SMAR

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

BMO Capital analyst John McNulty downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Market Perform to Underperform and lowers the price target from $138 to $76.

BMO Capital Downgrades Celanese to Underperform, Lowers Price Target to $76

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Mativ Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATV#NYSE">MATV</a>)</h3>
<ul>
<li>On Nov. 6, Mativ Holdings reported worse-than-expected third-quarter financial results. Chief Executive Officer Julie Schertell commented, &#8220;We saw meaningful increases in volume and profitability in Filtration and our overall SAS segment during the third quarter, with SAS segment adjusted EBITDA increasing almost 20% year over year. This was somewhat offset by results in Advanced Films, which were impacted by automotive and construction end markets." The company's stock fell around 12% over the past five days and has a <a href="https://www.benzinga.com/quote/MATV">52-week low of $10.78</a>.</li>
<li>RSI Value: 22.81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>MATV Price Action: Shares of Mativ dipped 21.1% to close at $13.73 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">latest MATV news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85.png" alt="" class="wp-image-637118" style="width:644px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08040959/image-85-768x700.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>)</h3>
<ul>
<li>On Nov, 4, Celanese reported worse-than-expected third-quarter financial results and announced it intends to temporarily reduce its quarterly dividend. &#8220;In the third quarter, we faced a severely constrained demand environment that, in some cases like auto, degraded swiftly. I want to thank our teams for executing our value enhancing initiatives that are delivering improvements today while also laying the foundation for future growth,&#8221; said Lori Ryerkerk, chair and chief executive officer. The company's stock fell around 29% over the past five days and h<a href="https://www.benzinga.com/quote/CE">as a 52-week low</a> of $89.12.</li>
<li>RSI Value: 14.38</li>
<li>CE Price Action: Shares of Celanese fell 2.9% to close at $89.72 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">trend in CE stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="911" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86.png" alt="" class="wp-image-637120" style="width:625px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041102/image-86-768x693.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">Ashland Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASH#NYSE">ASH</a>)</h3>
<ul>
<li>On Nov. 6, Ashland reported worse-than-expected fourth-quarter financial results and issued FY25 revenue guidance below estimates. &#8220;Customer demand was generally consistent with our expectations in the fourth quarter and all business units delivered organic sales volume growth,&#8221; said Guillermo Novo, chair and chief executive officer, Ashland. The company's stock fell around 5% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/ASH">low of $71.55</a>.</li>
<li>RSI Value: 25.90</li>
<li>ASH Price Action: Shares of Ashland fell 7.6% to close at $80.70 on Thursday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1">breakout in ASH shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent110824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="881" height="816" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87.png" alt="" class="wp-image-637121" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87.png 881w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08041157/image-87-768x711.png 768w" sizes="(max-width: 881px) 100vw, 881px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

MATV

Top 3 Materials Stocks That Are Preparing To Pump In Q4

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e3d7f5064ed0001730321/charles-neivert">Piper Sandler analyst Charles Neivert</a> downgraded the rating for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Underweight and lowered the price target from $150 to $98. Celanese shares closed at $89.72 on Thursday. <a href="https://www.benzinga.com/quote/CE/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Macquarie analyst Paul Golding downgraded Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from Outperform to Neutral but raised the price target from $91 to $99. Planet Fitness shares closed at $94.17 on Thursday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital analyst Mike Dahl downgraded the rating for Installed Building Products, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBP#NYSE">IBP</a>) from Sector Perform to Underperform and lowered the price target from $203 to $197. Installed Building Prods shares closed at $217.27 on Thursday. <a href="https://www.benzinga.com/quote/IBP/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Adrienne Yih downgraded Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) from Equal-Weight to Underweight and lowered the price target from $31 to $28. Bath &amp; Body Works shares closed at $31.75 on Thursday. <a href="https://www.benzinga.com/quote/BBWI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Matt Larew downgraded the rating for Maravai LifeSciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVI#NASDAQ">MRVI</a>) from Outperform to Market Perform. Maravai LifeSciences shares closed at $7.84 on Thursday. <a href="https://www.benzinga.com/quote/MRVI/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="539" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-1024x539.png" alt="" class="wp-image-637660" style="width:578px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-1024x539.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93-768x404.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/08084942/image-93.png 1255w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/41820056/how-to-earn-500-a-month-from-nvidia-stock-after-trump-win">How To Earn $500 A Month From Nvidia Stock After Trump Win</a></li>
</ul>

BBWI

MRVI

PLNT

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Piper Sandler analyst Charles Neivert downgrades Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Neutral to Underweight and lowers the price target from $150 to $98.

Piper Sandler Downgrades Celanese to Underweight, Lowers Price Target to $98

RBC Capital analyst Arun Viswanathan maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Outperform and lowers the price target from $163 to $122.

RBC Capital Maintains Outperform on Celanese, Lowers Price Target to $122

Deutsche Bank analyst David Begleiter upgraded Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) to Buy from Hold, lowering the price forecast to $110 from $135.
Celanese reported third-quarter adjusted earnings per share of $2.44, missing analyst estimates of $2.85. The company reported sales of $2.65 billion, missing analyst estimates of $2.7 billion, according to&nbsp;<a target="_blank" href="http://pro.benzinga.com/" rel="noreferrer noopener">Benzinga Pro</a>.
The analyst wasn&#8217;t surprised by Celanese missing third-quarter earnings and lowering fourth-quarter guidance.
For Begleiter, the shortfalls were due to weak demand in automotive, industrial and construction markets, which impacted many chemical companies this earnings season.
Particularly, the 57% fourth-quarter guidance shortfall surprised the analyst, but it was mainly due to temporary facility shutdowns to cut costs and reduce inventory.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41780680/super-micro-analysts-need-more-clarity-on-auditor-resignation-await-10-k-filing-man" rel="noreferrer noopener">Super Micro Analysts Need More Clarity On Auditor Resignation, Await 10-K Filing: &#8216;Management Did Not Address These Topics&#8217;</a>
Celanese likely misjudged the auto market, overproducing in the third quarter and creating excess inventory.
Begleiter added this won&#8217;t affect the company&#8217;s long-term earnings potential.
The analyst noted the 95% dividend cut should have happened two years ago when Celanese acquired DuPont&#8217;s Mobility &amp; Materials business for $11 billion.
Now, two years post-acquisition, Celanese is 5x leveraged (4.9x net debt to LTM EBITDA), leaving little margin for error.
The analyst suggested Celanese has strong operating leverage for a recovery, forecasting its EPS will rise from $10.50 in 2025 to over $14.50 by 2026, driven by factors such as interest rate cuts in Western countries, fiscal and monetary stimulus in China and several years of low industrial activity.
CE Price Action: Celanese shares are trading higher by 1.03% to $91.94 at publication Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41778433/s-p-500-dow-hit-record-highs-after-trump-win-fear-index-drops-20" target="_blank" rel="noreferrer noopener">S&amp;P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%</a></li>
</ul>

Equities

Movers

General

Deutsche Bank Upgrades Celanese Stock: Analyst Highlights Strong Leverage, Long-Term Growth

Barclays analyst Michael Leithead maintains Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) with a Equal-Weight and lowers the price target from $151 to $101.

Barclays Maintains Equal-Weight on Celanese, Lowers Price Target to $101

Worst performing stocks for tax loss selling – Wolfe

How is VOO stock faring? The Vanguard S&P 500 ETF is up 0.12% in the past five days and has risen 29.37% over the past year. According to TipRanks'...

VOO ETF Update, 12/17/2024

Evercore ISI analyst Eric Boyes maintained a Hold rating on Celanese (CE – Research Report) today and set a price target of $85.00. The company's s...

Evercore ISI Keeps Their Hold Rating on Celanese (CE)

Evercore ISI analyst Eric Boyes lowered the firm's price target on Celanese (CE) to $85 from $170 and keeps an In Line rating on the shares as a ne...

Celanese price target lowered to $85 from $170 at Evercore ISI

RBC Capital analyst Arun Viswanathan lowered the firm's price target on Celanese (CE) to $88 from $122 and keeps an Outperform rating on the shares...

Comments

Celanese

매도 수량

Celanese (NYSE:CE) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌